Study evaluates stem cells' ability to prevent major cause of death in preterm infants

Study evaluates stem cells' ability to prevent major cause of death in preterm infants
A phase 2 clinical trial whose results were released today in
STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung Medical Center, Sungkyunkwan University and Asan Medical Center Children's Hospital in Seoul, evaluates the effectiveness of treating these infants by transplanting umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas.
Early results showed signs of improvement for the most immature infants included in the trial.

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Anthony Atala ,Emily Henderson ,University Of Ulsan ,Asan Medical Center Children Hospital ,Samsung Medical Center ,Sungkyunkwan University ,Sungkyunkwan University School Of Medicine ,Wake Forest Institute For Regenerative Medicine ,Asan Medical Center Children ,Soon Park ,Sungkyunkwan University School ,Ellen Ai Rhan Kim ,Wake Forest Institute ,சியோல் ,தெற்கு கொரியா ,அந்தோணி அதல ,எமிலி ஹென்டர்சன் ,பல்கலைக்கழகம் ஆஃப் உல்சன் ,சாம்சங் மருத்துவ மையம் ,எழுந்திரு காடு நிறுவனம் க்கு மீளுருவாக்கம் மருந்து ,விரைவில் பூங்கா ,எழுந்திரு காடு நிறுவனம் ,